Cannabis consumer packaged goods company Green Thumb Industries Inc. GTII GTBIF will report its fourth-quarter financials on Tuesday. Cantor Fitzgerald‘s analyst Pablo Zuanic discussed his expectations in a recent note.
As with other operators in the space, price deflation and wholesale market erosion will negatively affect the gross figures reported by a company concerning revenues and sales, said Zuanic who is a speaker at the April Cannabis Capital Conference in Miami.
Zuanic retained an “Overweight” rating on the company’s stock while lowering his 12-month price target to $32 from $36.
Even though Green Thumb is still one of Zuanic’s top stock picks, he reduced estimates for the quarter though says he expects the company to benefit from trends evidenced in the states where it operates.
Benefits from the launch of cannabis sales in Rhode Island, expansion of medical marijuana sectors in Maryland and Virginia and maturing of New Jersey’s cannabis market should be visible in the first quarter of 2023, Zuanic said.
He expects a “-1% seq growth to $258Mn (FactSet consensus is at $257Mn)” for the fourth quarter.
“We continue to believe Green Thumb is arguably among the best-managed MSOs if we go by balance sheet strength, EBITDA/operating cash flow conversion, and profit margins (for a large footprint),” the analyst concluded.
GTI’s shares were trading 0.47% lower at $8.48 per share at the time of this publication on Monday morning.
Benzinga Cannabis Capital Conference
The most successful cannabis business event in the world, the Benzinga Cannabis Capital Conference, returns to Miami for its 16th edition.
This is the place where DEALS GET DONE, where money is raised, M&A starts, and companies meet investors and key partners. Join us at the Fontainebleau Miami Beach Hotel in Florida on April 11-12. Don’t miss out.
Secure your tickets now. Prices will surge very soon.
Photo: Courtesy of Markus Winkler on Unsplash